{"nct_id":"NCT05483933","title":"Phase 1b Study of SL-172154 Administered with Combination Agent(s) in Subjects with Ovarian Cancers","status":"COMPLETED","status_verified_date":"2025-02","start_date":"2022-08-18","start_date_type":"ACTUAL","primary_completion_date":"2025-02-07","primary_completion_date_type":"ACTUAL","completion_date":"2025-02-07","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["STTK"]}